Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Clinical trial NCT04066790 · TERMINATED
Trial details
- NCT number
- NCT04066790
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-09
- Primary completion
- 2020-04-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.